TrialExpert review of hematology2014

Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance.

Margaret V Ragni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.